Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

221 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness of JAK Inhibitors Compared With Biologic Disease-Modifying Antirheumatic Drugs on Pain Reduction in Rheumatoid Arthritis: Results From a Nationwide Swedish Cohort Study.
Eberhard A, Di Giuseppe D, Askling J, Bergman S, Bower H, Chatzidionysiou K, Forsblad-d'Elia H, Kastbom A, Olofsson T, Frisell T, Turesson C. Eberhard A, et al. Among authors: olofsson t. Arthritis Rheumatol. 2024 Sep 22. doi: 10.1002/art.43014. Online ahead of print. Arthritis Rheumatol. 2024. PMID: 39308007
Sex differences in patient-reported outcomes and the association with clinical factors in axial spondyloarthritis patients treated with tumour necrosis factor inhibitors.
Hellamand P, van de Sande MGH, Nurmohamed MT, van Vollenhoven RF, Hollick RJ, Rotariu O, Rotar Z, Pirkmajer KP, Nordström D, Hokkanen AM, Michelsen B, Kvien TK, Glintborg B, Hetland ML, Østergaard M, Loft AG, Pavelka K, Zavada J, Castrejon I, Otero-Varela L, Gudbjornsson B, Palsson O, Olofsson T, Wallman JK, Ciurea A, Nissen MJ, Yildirim TD, Onen F, Codreanu C, Mogosan C, Santos MJ, Vieira-Sousa E, Iannone F, Frediani B, Ørnbjerg LM, Twisk JWR, van der Horst-Bruinsma IE. Hellamand P, et al. Among authors: olofsson t. Rheumatology (Oxford). 2024 Jul 23:keae370. doi: 10.1093/rheumatology/keae370. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 39041780
Patient-reported outcomes in axial spondyloarthritis and psoriatic arthritis patients treated with secukinumab for 24 months in daily clinical practice.
Christiansen SN, Horskjær Rasmussen S, Pons M, Michelsen B, Glintborg B, Gudbjornsson B, Grondal G, Vencovsky J, Loft AG, Rotar Z, Pirkmajer KP, Nissen MJ, Baranová J, Macfarlane GJ, Jones GT, Iannone F, Caporali R, Laas K, Vorobjov S, Giuseppe DD, Olofsson T, Provan SA, Fagerli KM, Castrejon I, Otero-Varela L, van de Sande M, van der Horst-Bruinsma I, Nordström D, Kuusalo L, Bernardes M, Hetland ML, Østergaard M, Midtbøll Ørnbjerg L. Christiansen SN, et al. Among authors: olofsson t. Semin Arthritis Rheum. 2024 Apr;65:152388. doi: 10.1016/j.semarthrit.2024.152388. Epub 2024 Jan 26. Semin Arthritis Rheum. 2024. PMID: 38301349 Free article.
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial.
Østergaard M, van Vollenhoven RF, Rudin A, Hetland ML, Heiberg MS, Nordström DC, Nurmohamed MT, Gudbjornsson B, Ørnbjerg LM, Bøyesen P, Lend K, Hørslev-Petersen K, Uhlig T, Sokka T, Grondal G, Krabbe S, Lindqvist J, Gjertsson I, Glinatsi D, Kapetanovic MC, Aga AB, Faustini F, Parmanne P, Lorenzen T, Giovanni C, Back J, Hendricks O, Vedder D, Rannio T, Grenholm E, Ljoså MK, Brodin E, Lindegaard H, Söderbergh A, Rizk M, Kastbom A, Larsson P, Uhrenholt L, Just SA, Stevens DJ, Bay Laurbjerg T, Bakland G, Olsen IC, Haavardsholm EA, Lampa J; NORD-STAR study group. Østergaard M, et al. Ann Rheum Dis. 2023 Oct;82(10):1286-1295. doi: 10.1136/ard-2023-224116. Epub 2023 Jul 9. Ann Rheum Dis. 2023. PMID: 37423647 Clinical Trial.
221 results